Company
Products
Services
News
Career
Contact Us
Sitemap
FDA APPROVAL of our GMP facility !!
Polymed is delighted to announce that in December 2008 we received from the FDA the formal cGMP approval letter of our facility in China! The FDA inspected this facility in September 2008 for our Docetaxel and Oxaliplatin, and tentatively approved it then. Now that we have received the formal approval letter, our facility is formally accepted as cGMP by the FDA. Our FDA inspectors informed us that we are the first to be approved for Docetaxel in China and Far East! Our customers have been provided with the cover page of this approval letter, and all are very pleased that our facility is officially ‘cGMP’.